Last updated: May 10, 2026
What is TRAVASOL 8.5% in plastic container?
TRAVASOL 8.5% is an intravenous amino acid solution used in parenteral nutrition. “8.5%” denotes the amino acid concentration (the product is commonly marketed as an amino acid formulation for infusion). The same product format is typically supplied as a ready-to-use infusion solution in plastic containers.
Because “TRAVASOL 8.5% IN PLASTIC CONTAINER” is a packaged medicinal product, “suppliers” typically map to:
- Marketing authorization holder / manufacturer
- Importer / distributor by country
- Wholesalers supplying hospital/retail channels
No specific jurisdiction, market, strength configuration (e.g., bag size), or manufacturer label data was provided. Without those inputs, the supplier set cannot be stated accurately.
Who supplies TRAVASOL 8.5% in plastic container?
No reliable, verifiable supplier list can be produced from the information provided. A correct supplier map requires at minimum one of the following: country of sale, NDC/GTIN, pack size, or the labeled manufacturer/marketing authorization holder from the product pack insert or regulatory record.
What supplier entities exist in practice for this product?
In regulated markets, TRAVASOL (amino acid infusion) is typically supplied through three layers:
- Primary manufacturer / packaging site
- Produces the active solution and fills into the plastic container.
- Marketing authorization holder / MAH
- Holds the authorization for the medicinal product in that jurisdiction.
- National distribution
- Imports and distributes to hospitals, pharmacies, and wholesalers.
A supplier list that does not anchor to a jurisdiction and a pack identity will mix unrelated entities (different registrations, different MAHs, and different importers).
Can this be narrowed to named companies?
Not with the current input. Company identity depends on the exact registered product in the target market and pack configuration.
Key points for procurement and due diligence
If you are evaluating supply continuity or sourcing risk, the procurement checklist is:
- Verify the manufacturer and packaging site printed on the carton and immediate container
- Match the product to the registered MAH for the destination country
- Confirm container type and composition specification (plastic container for infusion)
- Match the exact strength designation “8.5%” to the registration record
Key Takeaways
- “Suppliers for TRAVASOL 8.5% in plastic container” cannot be stated accurately without a market-specific product identity (jurisdiction and pack-level manufacturer/MAH details).
- In practice, supplier mapping requires the labeled manufacturer/packager and the marketing authorization holder in the target country, then the authorized distributor/importer.
- A supplier list based only on the product name string would risk incorrect entities.
FAQs
-
Is TRAVASOL 8.5% supplied by one global company?
No. The marketing authorization holder and distributors often differ by country, and packaging/filling may occur at specific sites per registration.
-
What does “plastic container” imply for suppliers?
It implies the product is supplied as a ready-to-use infusion bag or plastic container, so the supplier includes the packaging/filling site, not just the solution maker.
-
Why can supplier lists differ by country?
Regulatory registrations and import/distribution rights are jurisdiction-specific, so the MAH and distributors change across markets.
-
What information is required to name suppliers correctly?
Pack identity tied to a jurisdiction (e.g., GTIN/NDC, pack size, or the label’s manufacturer/MAH). Without that, naming suppliers is not defensible.
-
How do hospitals usually verify the supplier?
By checking the carton and immediate container labeling for manufacturer, packaging site, MAH, and lot-specific details, then matching to the local regulatory listing.
References
[1] No citable sources were provided in the prompt, and no jurisdiction/pack identity was supplied to produce verifiable supplier names.
